Thalidomide-NH-PEG1-NH2
≥95%
- Product Code: 106466
CAS:
2138439-12-8
| Molecular Weight: | 360.36 g./mol | Molecular Formula: | C₁₇H₂₀N₄O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
Used primarily in the development of targeted drug delivery systems, this compound is designed to enhance the solubility and bioavailability of therapeutic agents. Its structure allows for conjugation with various drugs, improving their pharmacokinetic properties and reducing potential side effects. In cancer therapy, it is employed to create prodrugs that can selectively release active agents in tumor tissues, minimizing damage to healthy cells. Additionally, it is utilized in the synthesis of antibody-drug conjugates (ADCs), where it serves as a linker to attach cytotoxic drugs to monoclonal antibodies, enabling precise targeting of cancer cells. Its application also extends to research in immunomodulation, where it helps in studying the modulation of immune responses for treating autoimmune diseases and inflammatory conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿43,200.00 |
+
-
|
Thalidomide-NH-PEG1-NH2
Used primarily in the development of targeted drug delivery systems, this compound is designed to enhance the solubility and bioavailability of therapeutic agents. Its structure allows for conjugation with various drugs, improving their pharmacokinetic properties and reducing potential side effects. In cancer therapy, it is employed to create prodrugs that can selectively release active agents in tumor tissues, minimizing damage to healthy cells. Additionally, it is utilized in the synthesis of antibody-drug conjugates (ADCs), where it serves as a linker to attach cytotoxic drugs to monoclonal antibodies, enabling precise targeting of cancer cells. Its application also extends to research in immunomodulation, where it helps in studying the modulation of immune responses for treating autoimmune diseases and inflammatory conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :